Legend Biotech Reverses After J&J-Tied Cancer Drug Cuts Risk Of Death By 45%
In this article:
Legend Biotech reversed early gains Monday after the company said its J&J-tied multiple myeloma drug, Cavykti, cut the risk of death.
Advertisement
Legend Biotech reversed early gains Monday after the company said its J&J-tied multiple myeloma drug, Cavykti, cut the risk of death.